Balda AG: Balda AG and Mechatronic AG present newest version of their jointly developed app-controlled drug dispenser
10.02.2016
DGAP-Media / 10.02.2016 / 10:01
The Smart Drug Dispenser, which keeps track of tablets, is now 25% smaller.
Paris, February 10, 2016 – As previously reported, patients will soon be
able to dose their drugs via their smartphones. The medical technology
companies Balda AG and Mechatronic AG presented the Smart Drug Dispenser
for the first time at the CPhI Worldwide in Madrid this past October, and
received an innovation award at the Compamed in Düsseldorf the very next
month. The combination of app and easy-to-handle drug dispenser helps
prevent administration errors and thus unnecessary complaints or hospital
stays. They have now further developed the dispenser itself, making it
approximately 25% smaller for even easier handling.
A signal helping patients: The Smart Drug Dispenser makes an important
contribution to therapy safety. The physician or patient enters the number
of pills and the time when the medication is to be taken, via the app. The
device, which easily fits in the palm of your hand, stores the dosage
regimen and dispenses the tablets via the push of a button. The associated
smartphone app gives the user reminders – via text alerts and an acoustic
signal – until the proper dose has been dispensed. This prevents under- or
over dosage. Scientific figures show that this support is dearly needed.
Additionally, via the app, messages regarding missed doses could be sent to
someone supporting the patient.
Forgotten, mistaken or lost – over 50 per cent of medication is not taken
as prescribed. According to studies, one in four patients does not follow
the therapy regimen. Not necessarily on purpose. Surveys show that many
people simply forget to take their drugs. Consequences such as extended
healing processes, secondary diseases and additional trips to the doctor
are not only bothersome for the patients. The costs to the German
healthcare system alone, due to deficient compliance, are conservatively
estimated to be in excess of 10 billion EUR per year.
Christoph Klaus, Head of the Business Unit Balda Healthcare has recognized
the potential of the system: “An ageing population that is also tech-savvy
has a need for modern solutions. The Smart Drug Dispenser is an exciting
product that provides added value for patients, physicians, relatives and
also health insurers”.
Balda AG and Mechatronic AG will present their joint project on 10 and 11
February within the scope of the Pharmapack in Paris. Visitors may test the
Smart Drug Dispenser in Hall 54, booth 818 and see it on display at the
exclusive “Innovations Gallery”.
Photographic material is available via this link:
www.baldagroup.com/en/subnavigation/newsroom/downloads.html
Contact/Contact Person
Balda AG
Kathrin Wiederrich
Bergkirchener Str. 229
32549 Bad Oeynhausen
Tel: +49 5734 922 2023
Mobil: +49 176 19227157
www.balda-group.com
End of Media Release
—————————————————————————
Issuer: Balda AG
Key word(s): Health
10.02.2016 Dissemination of a Press Release, transmitted by DGAP – a service
of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
—————————————————————————
Language: English
Company: Balda AG
Bergkirchener Str. 228
32549 Bad Oeynhausen
Germany
Phone: +49 (0) 57 34 / 9 22-0
Fax: +49 (0) 57 34 / 9 22-2604
E-mail: ir@balda-group.com
Internet: www.balda-group.com
ISIN: DE0005215107
WKN: 521510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart
End of News DGAP Media
—————————————————————————
436065 10.02.2016